Quarterly report pursuant to Section 13 or 15(d)

Equity Transactions (Details Narrative)

v3.4.0.3
Equity Transactions (Details Narrative) - USD ($)
 3 Months Ended
Jan. 28, 2016
Dec. 01, 2015
Oct. 30, 2015
Mar. 21, 2015
Nov. 21, 2014
Nov. 12, 2014
Mar. 31, 2016
Mar. 31, 2015
Subscriptions recevied             $ 132,480  
Subscriptions for issuance per share price             $ 0.045  
Exercise price of common stock granted              
Number of stock options granted              
Expense recognized relating to stock options             $ 92,673 $ 64,496
Unrecognized stock based compensation expense             $ 819,816  
Songstagram [Member]                
Number of common stock shares issued for settlement and release of claims on certain assets acquired               820,000
Number of common stock issued for settlement and release of claims on certain assets acquired               $ 410,000
Employees [Member]                
Exercise price of common stock granted $ 0.02              
Number of restricted common stock shares issued during the period 9,011,324              
Rory Cutaia [Member]                
Number of warrants granted for consideration of extend the payment terms of note payables   8,920,593            
Note payable due date   Apr. 01, 2017            
Rory Cutaia [Member] | Executive Employment Agreement [Member]                
Exercise price of common stock granted         $ 0.50      
Number of stock options granted         800,000      
Number of stock options vested immediately         400,000      
Number of stock options expected to vest one year from execution date         400,000      
Number of stock options vested on each anniversary         250,000      
DelMorgan [Member]                
Unrecognized stock based compensation expense       $ 20,114        
Warrants granted to purchase of common stock shares       48,000        
Warrant exercise price per share       $ 0.10        
Warrants expire date       Mar. 20, 2018        
Consultant [Member]                
Warrants granted to purchase of common stock shares     600,000     600,000    
Warrant exercise price per share     $ 0.50     $ 0.50    
Warrants expire date     Oct. 30, 2020     Nov. 12, 2019    
Chief Executive Officer and a Board of Director [Member]                
Number of warrants granted for consideration of extend the payment terms of note payables   9,719,879            
Note payable due date   Apr. 01, 2017